DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Smith+Nephew’s OR3O Dual Mobility System; Medtronic Launches the Evolut FX Next-Gen TAVR System; FDA Approves Edwards’s Pascal Precision Transcatheter Valve Repair System; FDA Clearance to Zimmer Biomet’s Identity Shoulder System; Otsuka Announces Results of RADIANCE II Trial; Smith+Nephew Announces Data for its REGENETEN™ Bioinductive Implant Visit Post
2 How Is Digital Therapeutics Reshaping the Future of Healthcare? Visit Post
3 Rapid Medical’s TIGERTRIEVER 13; Glaukos’s Istent Infinite System; GE Healthcare’s Definium 656 HD; NeuroOne’s Signed Exclusive Development & Distribution Agreement with Zimmer; Kaia Health’s Rise-uP Randomized Controlled Trial; Bluejay’s Symphony IL-6 Test Visit Post
4 FDA Approval to Centinel’s Total Disc Replacement Devices; FDA clears DyAnsys' Neurostimulator; Orthox to Commence FFLEX Study; Cordis Started Enrolment for RADIANCY Clinical Study; Orthofix & LimaCorporate Announce Partnership; Medtronic to Partner With AWS Visit Post
5 Accleus’s Toro-L Interbody Fusion System; Labcorp’s New Test for Skin Cancer; SERA Prognostics’s Preterm Test; Endotronix’s SIRONA 2 Clinical Trial; Anumana’s AI Algorithm to Detect ECG Pulmonary Hypertension; Illumina’s Pan-cancer Companion Diagnostic Visit Post
6 BMS Sells NY Biologics Plant; FDA Approves Mitsubishi Tanabe’s Radicava, Love Pharma Acquires MicroDoz; Sandoz Launches Generic of Roche's Esbriet; Pfizer to Acquire Biohaven Pharma; eureKARE’s Cell and Gene Therapy CDMO; Atamyo’s LGMD Gene Therapies; FDA approves Eli Lilly's Type 2 Diabetes Treatment Visit Post
7 Assessing the Growing Role & the Demand of Apps in Managing the Chronic Diseases Visit Post
8 VBL Therapeutics’ VB-111 (ofranergene obadenovec); BMS’s mavacamten (Camzyos); Merck’s KEYTRUDA; AstraZeneca and Daiichi’s Enhertu; Pfizer/Biohaven’s VYDURA (rimegepant); AstraZeneca’s Ultomiris; Supernus’s Viloxazine (Qlebree); AbbVie’s Rinvoq Visit Post
9 MEDIT’s i700 Intraoral Scanner; Phantom Neuro and Blackrock’s Next-Generation Assistive Devices; Fresenius Medical’s Versi PD Cycler System; Franklin Mountain’s Dual Lumen Catheter for Cardiac Applications; Bioretec's Bioresorbable Implant; Vectorious’s VECTOR-HF II Study Visit Post
10 Knee Osteoarthritis Pipeline: Stepping Up to Get Bigger and Broader Visit Post
11 Penumbra’s Indigo System; Axonics’s F15 Recharge-free SNS; Stimwave’s FREEDOM-1 Clinical Trial; Virtual Incision’s MIRA Platform; SonoScape’s HD-550 Endoscopy system; SMART Medical’s G-EYE Colonoscope Series Visit Post
12 Investigating the Pipeline for Ankylosing Spondylitis Treatment Landscape Visit Post
13 Aidoc’s Pneumothorax; Cook Medical's Zenith Thoraco+ Endovascular System; GRAFIX Membrane Study; Corvia’s REDUCE LAP-HF II Trial Results; GE Healthcare and Imeka's Collaboration; Bioventus to Acquire CartiHeal Visit Post
14 Precigen's PRGN-3006; Yescarta Approved as a First CAR T-cell Therapy for R/R LBCL; Biogen & Ionis’ BIIB078; Nobelpharma's HYFTOR (sirolimus topical gel) 0.2%; Cerevance Parkinson’s Drug; Sanofi & Regeneron’s Dupixent; Clovis’s Rubraca for Ovarian Cancer; Immunocore Eye Cancer Cell Therapy Approval Visit Post
15 Evaluating the Top Players in the Global Bone Densitometers Market Visit Post
16 Össur Launches POWER KNEE; DePuy Synthes Acquires CrossRoads Extremity Systems; Myomo’s MyoPro; Accuray’s TomoTherapy System; Theradaptive’s Spinal Fusion Implant; Senseonics’s Eversense E3 CGM System Visit Post
17 Suneva Medical-Viveon Health merger update; Smith+Nephew acquires Engage Surgical; Abiomed's preCARDIA technology; Medtronic’s DTM Spinal Cord Stimulation; Endo Tools Therapeutics’s Endomina System; Diadem's AlzoSure predict prognostic blood test Visit Post
18 Siemens Healthineers’s COVID-19 Antigen Self-Test; Paragon’s R3ACT Stabilization System; Pulnovo Medical’s PADN-CFDA trial; Endotronix’s PROACTIVE-HF trial; Abbott’s Proclaim XR SCS System; RTI Surgical spins off businesses Visit Post
19 Cerner, Scanwell Health and Personal Genome Diagnostics Acquisition; Zynex's Fluid Monitoring System, CM-1500; Sight Sciences' TearCare System; Envista's Nobel Biocare N1 Implant System Visit Post
20 Neurent Medical’s NEUROMARK; Brain Navi NaoTrac received European CE Mark approval; Theradaptive receives Breakthrough Medical Device Designation; HAGAR GWave awarded Breakthrough Device Designation; Fujifilm launches ColoAssist PRO Visit Post
21 Abbott's Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ALung Technologies's Hemolung; AppliedVR’s EaseVRx; J&J to split into two companies; OrthAlign’s Lantern® launch; LumiThera’s Light-based Theranostic Visit Post
22 Bone Metastasis Market: A Debilitating Consequence for Many Tumors Visit Post
23 Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis Visit Post
24 Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ's HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune's Alzheimer's Antibody Drug Visit Post
25 Ascendis's SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin's Voxzogo; Zimmer-Canary's Smart Knee Implant; COVID-19 impact on Solid Organ Transplants Visit Post
26 Analyzing the Implication of Musculoskeletal Disorders and the Key Companies in the Therapeutics Market Visit Post
27 Diagnosis Delays, Ineffective Treatment Options Plaque the Bone Cancer Market Growth Visit Post
28 Pfizer hit by DMD delay & halts BCMA trials; Sarepta's drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic Visit Post
29 How Is Osteoporosis Impacting The Quality Of Life? Visit Post
30 MedTech Industry Roars Back as FDA Approvals Soar Visit Post
31 A New Addition to Existing Chimeric Antigen Receptor Therapies –Potential for a Game Changer in Blood Cancers Visit Post
32 Bright Peak, Ajinomoto to Create Novel Immunocytokines; FDA’s Rejection to Lilly/Pfizer's Tanezumab for Osteoarthritis Pain; Ikena Oncology Unveils IPO Pricing Visit Post
33 Emerging Therapies in the Chronic Pain Pipeline Transforming the Chronic Pain Market Landscape Visit Post
34 How Robots Are Introducing A New Dimension To Healthcare Service Delivery Visit Post
35 A Need for Curative Treatment Expected to Attract the Pharma Players in the Hallux Valgus Market Landscape Visit Post
36 Parkinson's Disease: How close are we to a cure? Visit Post
37 Santhera flunks DMD phase 3; Scribe emerges with $20 M; Merck sells off Osteoarthritis drug to Novartis; Research updates on flu vaccine and glioblastoma Visit Post
38 Thumbs down to NKTR-181, Lilly expands its insulin armamentarium Visit Post
39 Emerging drugs bring a positive shift in Global Osteoporosis Market Visit Post
40 World Osteoporosis Day Visit Post
41 FDA approves Bonsity for Osteoporosis treatment Visit Post
42 Juvenescence nets USD 100M; Sarepta DMD drug faces rejection Visit Post
43 Chronic Lower Back Pain Market Analysis Visit Post
44 Chronic Lower Back Pain Therapy Market Visit Post
45 Chronic Lower Back Pain Visit Post
46 Pompe Disease Scenario in Eastern Europe Visit Post
47 Pompe Disease Emerging Markets Visit Post
48 Pompe Disease Treatment Market Visit Post
49 Pompe Disease Market Visit Post
50 Amgen reveals price; Bardy raises $35.5M; Kiadis to Acquire CytoSen; Insitro lands a deal Visit Post
51 New Osteoporosis Drug promises to rebuild Bone Visit Post
52 AbbVie Receives Approval; Kymriah Approved; Shire Gets USFDA Approval; NICE Rejects; Bristol-Myers Squibb’s Opdivo; Eisai and Merck Get USFDA Approval Visit Post
53 Business Cocktail Visit Post
54 Business Cocktail Visit Post
55 Spasticity Visit Post
56 Takeda scores; PhRMA launches; Valeant's Obagi; Ex-Novo executive signs Visit Post
57 Roche, Boehringer tout; Pfizer, Bristol-Myers got sued; FDA commissioner unveils; EpicGenetics expands Visit Post
58 Sarcopenia: “Aging-Associated Strength Loss Condition” Visit Post
59 FDA Approves Sarepta’s Muscular Dystrophy Drug after Months of Debate Visit Post
60 Denali's Impressive Research Portfolio Visit Post
61 Duchenne Muscular Dystrophy Market Visit Post
62 Rheumatoid Arthritis Market, Epidemiology and Market Forecast-2020 Visit Post
63 DelveInsight’s Musculoskeletal disorders based Gene Therapy Reports Visit Post